000 01436 a2200361 4500
005 20250516154658.0
264 0 _c20140509
008 201405s 0 0 eng d
022 _a1535-9484
024 7 _a10.1074/mcp.M112.024927
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlves, Rodrigo D A M
245 0 0 _aActivin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production.
_h[electronic resource]
260 _bMolecular & cellular proteomics : MCP
_cOct 2013
300 _a2890-900 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aActivins
_xphysiology
650 0 4 _aAlkaline Phosphatase
_xmetabolism
650 0 4 _aCalcification, Physiologic
_xdrug effects
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aExtracellular Matrix
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMesenchymal Stem Cells
_xcytology
650 0 4 _aOsteoblasts
_xcytology
650 0 4 _aTransport Vesicles
_xmetabolism
700 1 _aEijken, Marco
700 1 _aBezstarosti, Karel
700 1 _aDemmers, Jeroen A A
700 1 _avan Leeuwen, Johannes P T M
773 0 _tMolecular & cellular proteomics : MCP
_gvol. 12
_gno. 10
_gp. 2890-900
856 4 0 _uhttps://doi.org/10.1074/mcp.M112.024927
_zAvailable from publisher's website
999 _c22848437
_d22848437